Arkolith/Insider Trading/OCX/Form 4

Broadwood Partners, L.P.

10% OwnerOncocyte Corp (OCX) · full profile →Form 4 · filed Apr 15, 2024
Net Buying
Open-Market Buys
$7.1M
Open-Market Sells
$0
Net Open-Market Flow
$7.1M
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 11, 2024Buy(P)2.4M$2.92$7.1M4.9M
Apr 11, 2024Buy(P)0—$04.9M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 15, 2024Other(J)3K——0
Apr 15, 2024Other(J)0——0

Transaction Codes

P
Open-market purchase
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000919574-24-002558) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML